Exact Mass: 411.0864422000001
Exact Mass Matches: 411.0864422000001
Found 110 metabolites which its exact mass value is equals to given mass value 411.0864422000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Mandipropamid
C23H22ClNO4 (411.1237282000001)
D016573 - Agrochemicals D010575 - Pesticides CONFIDENCE standard compound; EAWAG_UCHEM_ID 3061
Gonyautoxin I
Gonyautoxin I is found in mollusks. Gonyautoxin I is produced by Gonyaulax and Protogonyaulax species and isolated from shellfish. Neurotoxin, causal agent, with Saxitoxin, of shellfish poisoning. From Gonyaulax and Protogonyaulax subspecies Gonyautoxin IV is found in mollusks. D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms
Tiagabine hydrochloride
C20H26ClNO2S2 (411.10934060000005)
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D058805 - GABA Uptake Inhibitors C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D018377 - Neurotransmitter Agents > D018682 - GABA Agents D049990 - Membrane Transport Modulators Tiagabine hydrochloride is a potent and selective GABA reuptake inhibitor, used as an anticonvulsant agent, with IC50s of 67, 446 and 182 nM for [3H]GABA uptake in Synaptosomes, Neurons and Glia, respectively[1].
Carboxycelecoxib
C17H12F3N3O4S (411.05005880000004)
Carboxycelecoxib is a metabolite of celecoxib (PMID: 10681375). Celecoxib (trade name: Celebrex) is a sulfa non-steroidal anti-inflammatory drug (NSAID) and selective COX-2 inhibitor used in the treatment of osteoarthritis, rheumatoid arthritis, acute pain, painful menstruation, and menstrual symptoms, and to reduce numbers of colon and rectum polyps in patients with familial adenomatous polyposis. It is marketed by Pfizer. Celecoxib is available by prescription in capsule form (Wikipedia).
Sulfociprofloxacin
C17H18FN3O6S (411.09003000000007)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones
Cetocycline
C22H21NO7 (411.13179560000003)
Lintitript
C20H14ClN3O3S (411.0444364000001)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist
Sulfo-ciprofloxacin
C17H18FN3O6S (411.09003000000007)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones
4-[3-(trifluoromethyl)phenyl]-5-(3,4,5-trimethoxyphenyl)-4H-1,2,4-triazole-3-thiol
C18H16F3N3O3S (411.0864422000001)
N-acetylaspatyl-glutamyl-taurine-SO3
C13H21N3O10S (411.09476060000003)
3,7,8-tris(4-Hydroxyphenyl)-pyrrolo[2,1-c][1,4]oxazin-1-one
4-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-2-methoxy-, hydrogen sulfate (ester), (3S-trans)-Pheno
C19H22FNO6S (411.11518040000004)
Sulfociprofloxacin
C17H18FN3O6S (411.09003000000007)
An organosulfonic acid that is ciprofloxacin carrying a sulfo group at position 4 of the piperazine ring. It is a metabolite of ciprofloxacin. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones
Ethanone
(4-(N-Benzyl-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid
C21H22BNO5S (411.13116720000005)
Resorufin β-D-glucuronide sodium salt
C18H14NNaO9 (411.05662340000003)
N-(4-acetylphenyl)-4-hydroxy-N-[(4-methoxyphenyl)methyl]benzenesulfonamide
C22H21NO5S (411.1140376000001)
4-(4-TERT-BUTYLPHENYL)-N-(2-CHLOROPHENYL)-5-CYAN-AMIDE-4,5-DIHYDRO-1,3,4-THIADIAZOLE-2-CARBOXAMIDE
C20H18ClN5OS (411.09205280000003)
2,3,5-TRI-O-ACETYL-8-FLUORO ADENOSINE
C16H18FN5O7 (411.11902100000003)
2.4.6-TRICHLORO-1.3.5-TRIPHENYLBORAZINE
C18H15B3Cl3N3 (411.06106500000004)
4(1H)-Pyridazinone, 6-methyl-3-(2-quinolinylmethoxy)-1-(3-(trifluorome thyl)phenyl)-
(9H-Fluoren-9-yl)methyl 2,4-dichloro-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate
Adenosine, 1-methyl-,hydriodide (1:1)
C11H18IN5O4 (411.04034980000006)
G-1
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen
Thiazolidine, 2-(4-methylphenyl)-3-[(4-phenoxyphenyl)sulfonyl]- (9CI)
C22H21NO3S2 (411.09627960000006)
2,3,5-Tri-O-acetyl-2-fluoroadenosine
C16H18FN5O7 (411.11902100000003)
4-[1-[4-(AMINOSULFONYL)PHENYL]-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-5-YL]BENZOIC ACID
C17H12F3N3O4S (411.05005880000004)
9-Mesityl-10-methylacridinium perchlorate
C23H22ClNO4 (411.1237282000001)
Darinaparsin
C274 - Antineoplastic Agent > C177298 - Mitochondrial Targeting Antineoplastic Agent
3-(1,1-Dioxido-4h-1,2,4-Benzothiadiazin-3-Yl)-4-Hydroxy-1-(3-Methylbutyl)quinolin-2(1h)-One
C21H21N3O4S (411.1252706000001)
Bendamustine hydrochloride monohydrate
C16H24Cl3N3O3 (411.08831640000005)
Allyl-{4-[3-(4-bromo-phenyl)-benzofuran-6-yloxy]-but-2-enyl}-methyl-amine
4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile
C18H16F3N3O5 (411.10420020000004)
Methyl 3-Chloro-2-{3-[(2,5-Dihydroxy-4-Methoxyphenyl)amino]-3-Oxopropyl}-4,6-Dihydroxybenzoate
(6-chloro-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]methanone
2-methyl-3-{4-[4-(trifluoromethoxy)phenoxy]phenyl}quinolin-4(1H)-one
N-[3-(4-methyl-1-piperazinyl)-1,4-dioxo-2-naphthalenyl]benzenesulfonamide
C21H21N3O4S (411.1252706000001)
3-[6,6-dimethyl-3-(methylthio)-4-oxo-5,7-dihydro-2-benzothiophen-1-yl]-N-phenyl-1-pyrazolecarboxamide
4-chloro-3-(diethylsulfamoyl)-N-(2-nitrophenyl)benzamide
C17H18ClN3O5S (411.06556480000006)
5-cyclopropyl-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-7-(trifluoromethyl)-1,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide
C18H20F3N5OS (411.13405860000006)
N-[2-(2,3-dimethylphenyl)-5,5-dioxo-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]-2-methoxybenzamide
C21H21N3O4S (411.1252706000001)
N-(1,3-benzothiazol-2-yl)-2-(3-methoxyphenyl)-4-quinolinecarboxamide
2-(3-oxo-4H-1,4-benzothiazin-2-yl)acetic acid (7-methoxy-2-oxo-1-benzopyran-4-yl)methyl ester
C21H17NO6S (411.07765420000004)
2-(3-ethylphenoxy)-N-[4-(2-pyridinylsulfamoyl)phenyl]acetamide
C21H21N3O4S (411.1252706000001)
N-(1,3-benzothiazol-2-yl)-2-[[5-(4-methoxyphenyl)-4-methyl-1,2,4-triazol-3-yl]thio]acetamide
2-[[(6-Chloro-4-oxo-3-prop-2-enyl-2-quinazolinyl)thio]methyl]isoindole-1,3-dione
C20H14ClN3O3S (411.0444364000001)
2-(4-Ethoxy-3-methoxyphenyl)-3-(4-methoxyphenyl)-6-oxo-4-sulfanyl-1,2-dihydropyrimidine-5-carbonitrile
C21H21N3O4S (411.1252706000001)
2-(5-chloropyridin-2-yl)-4-[(E)-(5-ethyl-1,3,4-thiadiazol-2-yl)iminomethyl]-3-hydroxyisoquinolin-1-one
C19H14ClN5O2S (411.05566940000006)
(E)-2-(1H-benzimidazol-2-yl)-N-(furan-2-ylmethyl)-3-[3-(trifluoromethyl)phenyl]prop-2-enamide
N-{[(1S,2R)-1-carboxylato-2-hydroxypropyl]carbamoyl}adenosine
2-(4-bromophenyl)-1-(4-ethoxyphenyl)-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepin-4-ium
5-Carboxymethylaminomethyluridine 5-monophosphate
C12H18N3O11P (411.06789280000004)
(1R,2aS,8bS)-N-(4-chlorophenyl)-2-[cyclopropyl(oxo)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1S,2aR,8bR)-N-(4-chlorophenyl)-2-[cyclopropyl(oxo)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1S,2aS,8bS)-N-(4-chlorophenyl)-2-[cyclopropyl(oxo)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1R,2aR,8bR)-N-(4-chlorophenyl)-2-[cyclopropyl(oxo)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(2-amino-5,10,10-trihydroxy-6-imino-9-sulfooxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl)methyl carbamate
Lintitript
C20H14ClN3O3S (411.0444364000001)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist
Celecoxib Carboxylic Acid
C17H12F3N3O4S (411.05005880000004)
N-[(9-beta-D-ribofuranosylpurin-6-yl)carbamoyl]threonate
A hydroxy monocarboxylic acid anion that is the conjugate base of N-[(9-beta-D-ribofuranosylpurin-6-yl)carbamoyl]threonine, obtained by deprotonation of the carboxy group; major species at pH 7.3.
VU6019650
C18H22FN3O3S2 (411.10865540000003)
VU6019650 is a potent and selective orthosteric antagonist of M5 mAChR (IC50=36 nM), can be used for opioid use disorder (OUD) relief. VU6019650 can cross blood brain barrier, potentially modulates the mesolimbic dopaminergic reward circuitry. VU6019650 blocks Oxotremorine M iodide (HY-101372A) induced increases of neuronal firing rates of midbrain dopamine neurons in the ventral tegmental area (VTA)[1][2].
3,4-dihydroxyphenethyl
C19H23BrClNO2 (411.06005880000004)
{"Ingredient_id": "HBIN007409","Ingredient_name": "3,4-dihydroxyphenethyl","Alias": "NA","Ingredient_formula": "C19H23BrClNO2","Ingredient_Smile": "C1CN(CCC1C2=CC=C(C=C2)Cl)CCC3=CC(=C(C=C3)O)O.Br","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "32830","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(1r,4ar,12as)-3-acetyl-1-amino-4,4a,6,7-tetrahydroxy-8,11-dimethyl-12,12a-dihydro-1h-tetracene-2,5-dione
C22H21NO7 (411.13179560000003)
[5,10,10-trihydroxy-2,6-diimino-9-(sulfooxy)-hexahydropyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid
(2s,3r,4s,5r,6s)-6-(4-{[(2-ethoxy-2-sulfanylideneethylidene)amino]methyl}phenoxy)-4,5-dihydroxy-2-methyloxan-3-yl acetate
[(3as,4r,9r)-5,10,10-trihydroxy-2,6-diimino-9-(sulfooxy)-hexahydropyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid
(5s,8s,9r)-8-benzoyl-2-(5-ethylfuran-2-yl)-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one
C22H21NO7 (411.13179560000003)
n-(4,7-dihydroxy-8-methyl-2-oxochromen-3-yl)-4-hydroxy-3-[(2s)-2-hydroxy-3-methylbut-3-en-1-yl]benzenecarboximidic acid
C22H21NO7 (411.13179560000003)
(5r,8s,9s)-8-benzoyl-2-(5-ethylfuran-2-yl)-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one
C22H21NO7 (411.13179560000003)
2,3,4,6,7-pentahydroxy-1h,2h,3h,4h,4ah,9h,11bh-[1,3]dioxolo[4,5-j]phenanthridin-1-yl 3-hydroxybutanoate
n-[6-(2-hydroxy-3,4,5-trimethoxyphenyl)-2h-naphtho[2,3-d][1,3]dioxol-5-yl]-n-methylformamide
C22H21NO7 (411.13179560000003)
(3as,4r,9r,10as)-6-amino-10,10-dihydroxy-4-[(c-hydroxycarbonimidoyloxy)methyl]-2-imino-9-(sulfooxy)-1h,3h,3ah,4h,8h,9h-pyrrolo[1,2-c]purin-5-ium-5-olate
(5r,8s,9r)-8-benzoyl-2-(5-ethylfuran-2-yl)-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one
C22H21NO7 (411.13179560000003)
(1r,2r,3s,4s,4ar,11br)-2,3,4,6,7-pentahydroxy-1h,2h,3h,4h,4ah,9h,11bh-[1,3]dioxolo[4,5-j]phenanthridin-1-yl (3s)-3-hydroxybutanoate
n-(4,7-dihydroxy-8-methyl-2-oxochromen-3-yl)-4-hydroxy-3-(2-hydroxy-3-methylbut-3-en-1-yl)benzenecarboximidic acid
C22H21NO7 (411.13179560000003)
(5s,8s,9s)-8-benzoyl-2-(5-ethylfuran-2-yl)-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one
C22H21NO7 (411.13179560000003)
8-benzoyl-2-(5-ethylfuran-2-yl)-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one
C22H21NO7 (411.13179560000003)